GL Ventures — 2020 Investments

2 investments dated 2020 · listed companies and verified rows first · show all

Abogen Biosciences (艾博生物)abogenbio.comNov 2020

Abogen Biosciences is a clinical-stage biotechnology company developing RNA-based medicines, with in-house capabilities spanning the full mRNA drug development cycle including protein engineering, mRNA sequence design and synthesis, lipid nanoparticle delivery, formulation, and commercial-scale manufacturing.

BiotechDeep TechHealthtech

Bo Ying(Founder)

Co-investors5Y Capital Coatue Management Fuzhou Jiebao Rongan Venture Capital Qiming Venture Partners SoftBank Vision Fund Boyu Capital +7 more

DXYdxy.cnDec 2020 · $500M

DXY (丁香园) is China's leading digital healthcare technology company that connects doctors, patients, hospitals, pharmaceutical companies, and consumers through professional medical content, health data, and digital health services.

Digital HealthEdTechHealthtechSaaSHangzhou, CN

Tiantian Li(Founder)in

Co-investorsDCM Ventures Shunwei Capital DCM Trustbridge Partners

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.